Self-assembled polymeric nanoparticles for percutaneous co-delivery of hydrocortisone/hydroxytyrosol: An ex vivo and in vivo study using an NC/Nga mouse model

International Journal of Pharmaceutics

Volumn 444, Issue 1-2, 2013, Pages 109-119

  Hussain, Zahid ^a   Katas, Haliza ^a   Mohd Amin, Mohd Cairul Iqbal ^a   Kumolosasi, Endang ^a   Buang, Fhataheya ^a   Sahudin, Shariza ^a  

^a UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

Author keywords

Allergic contact dermatitis; Corticosteroid; Polymeric nanoparticles; Polyphenol; Topical co delivery

Indexed keywords

CHITOSAN; HYDROCORTISONE; HYDROXYTYROSOL; NANOPARTICLE; POLYMER;

ANIMAL EXPERIMENT; ARTICLE; ATOPIC DERMATITIS; DRUG DELIVERY SYSTEM; DRUG FORMULATION; EPIDERMIS; ERYTHEMA; EX VIVO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PARTICLE SIZE; PH; PRIORITY JOURNAL; WATER LOSS; ZETA POTENTIAL;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CHITOSAN; DERMATITIS, ATOPIC; DINITROFLUOROBENZENE; DISEASE MODELS, ANIMAL; DRUG CARRIERS; HYDROCORTISONE; MICE; NANOPARTICLES; PHENYLETHYL ALCOHOL; SKIN; SKIN ABSORPTION;

EID: 84873702901     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.01.024     Document Type: Article

References (36)

1. W.Y. Almawi, and O.K. Melemedjian Molecular mechanisms of glucocorticoid antiproliferative effects: antagonism of transcription factors activity by glucocorticoid receptor J. Leukoc. Biol. 71 2002 9 15
2. A. Alomar, J. Berth-Jones, and J.D. Bos The role of topical calcineurin inhibitors in atopic dermatitis Br. J. Dermatol. 151 2004 3 27
3. M.R. Avadi, A.M.M. Sadeghi, M. Mohammadpour, S. Abedin, F. Atyabi, R. Dinarvand, and R.T. Morteza Preparation and characterization of insulin nanoparticles using chitosan and Arabic gum with ionic gelation method Nanomedicine: Nanotechnol. Biol. Med. 6 2010 58 63
4. B.W. Barry Novel mechanisms and devices to enable successful transdermal drug delivery Eur. J. Pharm. Sci. 14 2001 101 114
5. B. Biruss, and C. Valenta Skin permeation of different steroid hormones from polymeric coated liposomal formulations Eur. J. Pharm. Biopharm. 62 2006 210 219
6. J.D. Bos Non-steroidal topical immunomodulators provide skin-selective, self limiting treatment in atopic dermatitis Eur. J. Dermatol. 13 2003 455 461
7. Z.Z. Dai, J.B. Yin, S.F. Yan, T. Cao, J. Ma, and X.S. Chen Polyelectrolyte complexes based on chitosan and poly (l-glutamic acid) Polym. Int. 56 2007 1122 1127
8. Daniel, R.; Nathalie, R.; Joseph, S.; wertz, K.; 2011. Novel composition and use thereof for the treatment, co-treatment or prevention of inflammatory disorders, US Patent Application 2011/0014308 A1.
9. M.A. Dohil, and L.F. Eichenfield A treatment approach for atopic dermatitis Pediatr. Ann. 34 2005 201 210
10. F. Gioia, and C. Leonardo The dynamics of TEWL from hydrated skin Skin Res. Technol. 8 2002 178 186
11. M. Grewe, C.A. Bruijnzeel-Koomen, and E. Schopf A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis Immunol. Today 19 1998 359 361
12. M. Grillo, M. Ng, and L. Gassner Pediatric atopic eczema: the impact of an educational intervention Pediatr. Dermatol. 23 2006 428 436
13. W. He, X. Guo, and M. Zhang Transdermal permeation enhancement of N-trimethyl chitosan for testosterone Int. J. Pharm. 356 2008 82 87
14. D. Hepburn, J.J. Yohn, and W.I. Weston Topical steroid treatment in infants, children and adolescents Adv. Dermatol. 9 1994 225 254
15. D.Y. Leung Atopic dermatitis: new insights and opportunities for therapeutic intervention J. Allergy Clin. Immunol. 105 2000 860 876
16. J.H. Kim, Y.S. Kim, S. Kim, J.H. Park, K. Kim, K. Choi, H. Chung, S.Y. Jeong, R. Park, I. Kim, and I.C. Kwon Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel J. Control. Release 111 2006 228 234
17. T. Kim, J. Jung, G. Kim, A. Jang, H. Ahn, Y. Park, and C. Park Melatonin inhibits the development of 2, 4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions in NC/Nga mice J. Pineal Res. 47 2009 324 329
18. N. Kohyama, T. Nagata, S. Fujimoto, and K. Sekiya Inhibition of arachidonate lipoxygenase activities by 2-(3 4-dihidroxyphenyl) ethanol, a phenolic compound from olives Biosci. Biotechnol. Biochem. 61 1997 347
19. C. Manna, P. Galletti, V. Cucciola, G. Montedoro, and V. Zappia Olive oil hydroxytyrosol protects human erythrocytes against oxidative damages J. Nutr. Biochem. 10 1999 159
20. H. Matsuda, N. Watanabe, G.P. Geba, J. Sperl, M. Tsudzuki, J. Hiroi, M. Matsumoto, H. Ushio, S. Saito, P.W. Askenase, and C. Ra Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice Int. Immunol. 9 1997 461 466
21. M. Matsumoto, N. Umemoto, H. Sugiuta, and M. Uehara Differences in ceramide composition between "dry" and "normal" skin in patients with atopic dermatitis Arch. Dermatol. Res. 79 1999 246 247
22. K. Moser, K. Kriwet, A. Naik, Y.N. Kalia, and R.H. Guy Passive skin penetration enhancement and its quantification in vitro Eur. J. Pharm. Biopharm. 52 2001 103 112
23. C. Padula, F. Sartori, F. Marra, and P. Santi The influence of iontophoresis on acyclovir transport and accumulation in rabbit ear skin Pharm. Res. 22 2005 1519 1524
24. S. Papadimitriou, D. Bikiaris, and K. Avgoustakis Chitosan nanoparticles loaded with dorzolamide and pramipexole Carbohydr. Polym. 73 2008 44 54
25. E. Park, K. Park, H. Eo, J. Seo, M. Son, K. Kim, Y. Chang, S. Cho, K. Min, M. Jin, and S. Kim Suppression of spontaneous dermatitis in NC/Nga murine model by PG102 isolated from Actinidia arguta J. Invest. Dermatol. 127 2007 1154 1160
26. R. De la Puerta, V.R. Gutierre, and J.R.S. Hoult Inhibition of leukocyte lipoxygenase by phenolics from virgin olive oil Biochem. Pharmacol. 57 1999 445 449
27. S. Schoepe, H. Schacke, E. May, and K. Asadullah Glucocorticoid therapy-induced skin atrophy Exp. Dermatol. 15 2006 406 420
28. T. Şenyiǧit, C. Padula, Ö. Özer, and P. Santi Different approaches for improving skin accumulation of topical corticosteroids Int. J. Pharm. 380 2009 155 160
29. T.L. Sung, L.M. Fwu, J.S. Yu, and S.S. Shin Equilibrium and kinetic studies of copper (II) ion uptake by chitosan-tripolyphosphate chelating resin Polymer 42 2001 1879 1892
30. Y. Werner, and M. Lindberg Transepidermal water loss in dry and clinically normal skin in patients with atopic dermatitis Acta Derm. Venereol. 65 1985 102 105
31. W. Wu, W. Yang, C.C. Wang, J.H. Hu, and S.K. Fu Chitosan nanoparticles as a novel delivery system for ammonium glycyrrhizinate Int. J. Pharm. 295 2005 235 245
32. X. Wu, G.J. Price, and R.H. Guy Disposition of nanoparticles and an associated lipophilic permeant following topical application to the skin Mol. Pharmacol. 6 2009 1441 1448
33. Y.T. Wu, and C.L. Grant Effect of chelation chemistry of sodium polyaspartate on the dissolution of calcite Chem. Biomol. Eng. 18 2002 6813 6820
34. Y.M. Xu, and Y.M. Du Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles Int. J. Pharm. 250 2003 215 226
35. M.A. Yamane, A.C. Williams, and B.M. Barry Terpene penetration enhancers in propylene glycol-water co-solvents systems: effectiveness and mechanism of action J. Pharm. Pharmacol. 47 1995 978 989
36. N.N. Zöller, S. Kippenberger, D. Thaçi, K. Mewes, M. Spiegel, A. Sattler, M. Schultz, J. Bereiter-Hahn, R. Kaufmann, and A. Bernd Evaluation of beneficial and adverse effects of glucocorticoids on a newly developed full-thickness skin model Toxicol. In Vitro 22 2008 747 759